Flat optic versus diffractive lens array for 755-nm picosecond laser treatment of melasma-associated photoaging: a randomized split-face trial in Chinese women
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Introduction Facial aging in Asian populations presents unique challenges, as photoaging frequently coexists with melasma, and conventional laser treatments carry elevated post-inflammatory hyperpigmentation (PIH) risk. The comparative efficacy of different 755-nm picosecond alexandrite laser (PSAL) delivery systems remains unclear. This study aims to compare the efficacy and safety of 755-nm PSAL flat optic versus diffractive lens array (DLA) for facial rejuvenation in Chinese women with Fitzpatrick skin types III-IV and melasma. Methods This randomized split-face trial enrolled 80 Chinese women with symmetrical facial photoaging and melasma. Participants received six treatment sessions at 4-week intervals followed by 24 months of follow-up. Primary outcome was the mean change in the dyschromia score from baseline to 4 weeks after the third treatment. Secondary outcomes included changes in scores for skin laxity, rhytids, and texture at all follow-up points, melasma improvement using the hemi-Melasma Area and Severity Index (hemi-MASI), patient satisfaction, histological changes and safety. Results Seventy-eight participants (mean age 42.95 ± 8.19 years) completed follow-up. Both delivery systems significantly improved photoaging and melasma. Flat optic demonstrated slightly greater pigment reduction after six sessions (mean dyschromia score: 1.60 vs. 1.65 for DLA; mean hemi-MASI score: 3.76 vs. 3.82), lower PIH incidence (35.9% vs. 60.3%, P = 0.002), and shorter recovery (60.7% recovered within 1 week vs. 27.7% requiring >4 weeks with DLA). Analysis of skin texture revealed a significant time-by-treatment interaction ( P = .02), indicating that the efficacy profiles of the two treatments differed significantly over time. Histological analysis did not detect a statistically significant difference between the groups for collagen and elastin density. Pain scores favored flat optic (4.18 vs. 5.83; P < 0.001). No significant difference was found in long-term outcomes. Discussion Flat optic PSAL offers a more favorable safety profile, characterized by lower PIH incidence and less pain, for PIH-prone patients with Fitzpatrick skin types III-IV, supporting its valuable option for treating photoaging and melasma in sensitive skin types. Clinical Trial Registration https://www.chictr.org.cn/ , Identifier ChiCTR2200065607.
Source: Frontiers in Medicine
Authors: Qilin Sun(Data curation, Investigation, Validation, Writing – original draft), Yang Liu(Data curation, Investigation, Methodology, Software, Supervision, Writing – review & editing), Qingqing Cen(Formal analysis, Investigation, Methodology, Resources, Writing – review & editing), Yue Han(Data curation, Formal analysis, Investigation, Software, Writing – review & editing), Ying Shang(Data curation, Formal analysis, Supervision, Visualization, Writing – review & editing), Gang Ma(Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing), Pinru Wu(Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing – review & editing)
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234325181
